LATEST ALERTS
CBD-Intel COVID-19 news round-up
30th April 2020 - News analysis |
In order to help you keep track of how all this is affecting the CBD industry around the world, all CBD-Intel’s COVID-19-related coverage can now be found in one place here
Health and science
Canada seeks experts to advise on non-prescription cannabis health products
23rd April 2020 - News analysis |
A new national committee is to be set up in Canada to study all aspects of non-prescription cannabis health products, including CBD products
CBD companies are advised to use the time well as virus slows regulation
15th April 2020 - News analysis |
CBD entrepreneur Christina DiArcangelo tells CBD-Intel that businesses should be using the slowdown to study, reflect, plan – and “get ahead of the ball”
Anxiety, doubt – and some optimism – over coronavirus impact on CBD in US
14th April 2020 - News analysis |
The wider impact of COVID-19 on the CBD sector in the US remains confused in the short term and largely a mystery in the longer term as companies scramble to gather information
It’s not toxic – but is CBD effective? That’s the question for research team
9th April 2020 - News analysis |
Liver toxicity is not really an issue for CBD, but questions remain about its efficacy and how it may affect the efficacy of other drugs. That’s according to leading cannabinoids researcher Kent Vrana
Industry bodies accuse ‘predatory marketers’ of spreading false claims
30th March 2020 - News analysis |
Industry organisations have responded in anger to continued claims being made by some companies about the supposed power of cannabinoids in tackling COVID-19
Denver-to-Dallas move goes ahead despite coronavirus outbreak
25th March 2020 - News analysis |
Also: GW suggests another possible use for Epidyolex; Lawsuit alleges hemp plants were contaminated with pesticide; Elixinol rebrands to move away from medicinal image; Kentucky hemp business goes bust
FDA needs more data before making CBD rules, Hahn tells US hearing
25th March 2020 - News analysis |
FDA commissioner Stephen Hahn has told a Congressional subcommittee that more research and data are needed before the FDA is ready to issue a formal policy on CBD products
US authorities stamp down on false claims of anti-coronavirus properties
23rd March 2020 - News analysis |
Bogus claims that products containing CBD may have any beneficial effects in treating or warding off coronavirus risk the wrath of authorities in the US – and could ultimately damage CBD’s reputation
CBD events called off or put back as coronavirus tightens grip
19th March 2020 - News analysis |
As the COVID-19 pandemic continues to affect people across the world, a swathe of CBD-related events have been called off or postponed. Here is a list of some of the major ones, with dates and details
Test methods put to the test as firms are accused of exceeding THC limits
17th March 2020 - News analysis |
Unclear testing standards for CBD oil in the UK have led to uncertainty over test results on THC and CBD content for many popular CBD products
Epidiolex passes another clinical trial for treatment of Dravet syndrome
11th March 2020 - News analysis |
Results from a successful phase three clinical trial on the use of Epidiolex to treat drug-resistant Dravet syndrome have been published in the JAMA Neurology journal
Clinical researchers seek funding to gather data on CBD and the liver
3rd March 2020 - News analysis |
A company is looking to use broader evidence permissions to provide the US Food and Drug Administration (FDA) with data on CBD and liver toxicity
Toothpaste giant enters CBD market: business news in brief
26th February 2020 - News analysis |
Toothpaste giant Colgate is entering the CBD market, researchers have created a laser scanner that can tell the difference between legal hemp and potentially illegal cannabis, and wrestling legend Kevin Nash has become the latest celebrity to endorse CBD, plus more
Our new special intelligence service covers the alternative tobacco field
25th February 2020 - News analysis |
TobaccoIntelligence, a new service from the team that produces CBD-Intel, is now available, covering the global tobacco and nicotine alternatives sector
BfR issues warning over adulterated German e-liquids
21st February 2020 - News analysis |
Germany’s Federal Institute for Risk Assessment (BfR) recently issued a warning on e-liquids that it believed to be containing synthetic cannabinoids, after at least eight teenagers suffered medical complications from an as yet unconfirmed source
Actor refutes claims he endorsed CBD products: business news in brief
18th February 2020 - News analysis |
Tom Hanks refutes false claims over endorsement of CBD products, research suggests cannabinoids benefit gene receptor diseases and CBD coffee is set to hit the market, plus more
Vital directives still to come as Peru pieces together full regulation
11th February 2020 - News analysis |
Peru is moving towards comprehensive legislation on cannabis but has yet to define how to classify CBD, leaving the guidelines unworkable for now
Researchers aim for a certified safer alternative to painkiller ibuprofen
23rd January 2020 - News analysis |
A US-based hemp research firm is working with a university in Florida to create an FDA-approved capsule that could replicate the painkilling abilities of ibuprofen
Can CBD help make anticancer drugs and antibiotics more effective?
22nd January 2020 - News analysis |
Two new studies have shown hopeful signs that CBD could be combined with existing drugs to improve treatment – in one case, of cancer, and in the other of the potentially deadly E. coli
Charity invests in CBD trials for Parkinson’s symptom relief
14th January 2020 - News analysis |
As more victims of Parkinson’s disease turn to CBD to relieve symptoms such as tremors, anxiety and insomnia, Parkinson’s UK is investing in a clinical trial into how CBD might benefit those suffering Parkinson’s-related psychosis
Where professional athletes lead on CBD topicals, other users will follow
30th December 2019 - News analysis |
The CBD sports topicals sector has grown significantly in the last year, with many UK high street retailers now stocking CBD massage oils and recovery balms
Calls for new regulation after ‘vape-related’ death of Belgian teenager
19th December 2019 - News analysis |
Regulation in Belgium and possibly across Europe may change as a result of the link being made between CBD vaping and a teenager’s death – though that link has not been verified
Two CBD products approved under Irish medical cannabis programme
17th December 2019 - News analysis |
The Irish government has given approval to two CBD-based medicines as it starts its medical cannabis programme
Video: Brexit round table
7th December 2019 - Resources , Videos |
The organisers of Hemp and CBD Expo invited our MD, Tim Phillips, to participate in their round table about Brexit. Their aim was to objectively understand what the Brexit impacts are going to be over the next few years for CBD and the UK CBD industry. Don’t miss out on this interesting debate. If you are looking for UK regulatory » Continue Reading.
FDA cracks down again on health claims, but seems receptive to CBD
26th November 2019 - News analysis |
Scrutiny of the CBD market appears to be growing at the US Food and Drug Administration (FDA), which this week reprimanded a further 15 companies for selling CBD products as drugs and also updated its advice to consumers on potential dangers
Welcome to CBD-Intel’s podcast series
25th November 2019 - Podcasts , Resources |
CBD-Intel’s regular podcasts provide expert insight into global regulation, market trends and the latest developments. Join us to find out more about this fast-moving industry with the CBD-Intel team. Thanks for listening!
A NICE change of heart as UK approves CBD-based medicines after all
21st November 2019 - News analysis |
Official approval by the UK National Institute for Health and Care Excellence (NICE) of the drugs Epidyolex and Sativex will be seen by many as a positive sign of growing acceptance of cannabis-based medicines
CBD ‘most searched health term in the US’: CBD business news in brief
4th November 2019 - News analysis |
According to research from San Diego State University, CBD is the most searched health term in the US. Also covered are further stories from the US, Australia, India, Italy and Switzerland
Hemp extraction proposal falls short of solving Italian regulation chaos
4th November 2019 - News analysis |
A proposal to regulate the sale of hemp biomass in Italy has been put before the Agriculture Committee of the Chamber of Deputies, but members of the industry fear it does not go far enough in allowing use of the plant
Full-spectrum products are ‘the future’, says pro-hemp vet
29th October 2019 - News analysis |
California vet Tim Shu, founder of Vet CBD and Dr Shu’s Pet Care, discusses the future of full-spectrum products, cannabinoid therapeutics, and the need for further research and regulation
Product liability claim over vape-related injury a threat to CBD industry
28th October 2019 - News analysis |
A product liability lawsuit filed in Washington state could be a very serious issue for the CBD industry in the near future, especially following the ongoing lung-related illness outbreak
Research reveals how CBD offsets mentally disturbing effects of THC
17th October 2019 - News analysis |
Researchers in Canada have for the first time revealed how CBD can block unwanted THC-related side-effects of cannabis. Also: Can CBD relieve anxiety disorders? and the therapeutic potential of ‘Turbo’ oil tested
US health organisations respond to rise of CBD with cautious optimism
17th October 2019 - News analysis |
Medical associations in the US say they are optimistic about the potential for CBD to treat patients, but have warned people to proceed with caution when treating themselves due to a lack of rigorous scientific studies
CBD firms are urged to scrub up on farming, testing and ‘hollow claims’
16th October 2019 - News analysis |
Leading CBD sellers in the US have been urged to clean up their act by the Center for Food Safety (CFS) after a “scorecard” survey revealed supply chain failings – from farm to point of sale
US universities take positive steps for hemp research and innovation
15th October 2019 - News analysis |
Funding success for new developments in hemp research, as well as innovations such as monitoring the path of pollen using drones
Sportspeople shown to be effective for endorsing CBD products – for now
10th October 2019 - News analysis |
The relative newness of CBD means brands will look to get big names to endorse it – but as the product becomes more known and accepted, this could all change
Trials test link between marijuana and autism: CBD-Intel news in brief
9th October 2019 - News analysis |
CBD-Intel brings you business and related news in brief from the US, China, Israel and UK
Lung outbreak: CDC, FDA now focused on THC, but public more worried by nicotine
4th October 2019 - News analysis |
The American public believes nicotine e-cigarettes to be more dangerous than THC vaping, even as official statements on the recent outbreak of lung disease start to emphasise the role of cannabis and play down the involvement of nicotine products
CBD-Intel regulatory news in brief, 26th-30th September
30th September 2019 - Alerts , News analysis , Regulatory alerts roundup |
Moves are under way in a number of US states to take executive action against various vapour products. Meanwhile, a Kentucky CBD firm is suing for $44m an Oregon company it says sold it “nearly worthless” hemp seeds
Good evidence – and the lack of it: CBD-Intel science news in brief
25th September 2019 - News analysis |
Scientific studies reveal varying views on the use of CBD and cannabis in treating PTSD, HIV, depression, anxiety and stress, while parents are warned not to give CBD to their children
US lung outbreak: despite likely role of THC, most still blame vaping itself
23rd September 2019 - News analysis |
The cannabis and CBD sectors have thus far remained remarkably unscathed by the lung illness outbreak in the US, despite a growing suspicion that in at least many cases, the culprit may be THC oil bought from street sources
Study urges patients, physicians and CBD users to consider the evidence
19th September 2019 - News analysis |
A new review of CBD science from the Mayo Clinic in the US aims to help doctors prescribe “evidence-based formulations”
NFL’s brightest stars come out for CBD – the league’s chief medic still says no
12th September 2019 - News analysis |
The chief medical officer of the US National Football League (NFL) remains wary of letting players use CBD, despite a number of stars coming forward to endorse it
CBD regulatory news in brief, 3rd – 9th September
9th September 2019 - Alerts , News analysis , Regulatory alerts roundup |
South Dakota governor Kristi Noem has explained why she continues to oppose hemp legalisation in the state; Flanders in Belgium is seeing enforcement action against CBD shops because of CBD oils and teas; Australian state Victoria may yet see hemp farming legalised as attitudes appear to be softening; and much more…
California hemp bill delays legalisation of foods, beverages and cosmetics with hemp-based CBD
9th September 2019 - News analysis |
The launch of many CBD-containing foods, beverages and cosmetics in California has been delayed further as a bill legalising their sale is now not expected to pass before the end of the legislative session, which ends on on 13th September
CBD-Intel regulatory news in brief, 27th August-2nd September
2nd September 2019 - Alerts , News analysis , Regulatory alerts roundup |
Americans for Safe Access has issued the Patient’s Guide to CBD, Ireland sees increase in hemping-growing licence applications, and over 6000 plants have been seized in Portugal
CBD drug Epidyolex looks unlikely to get a NICE answer in the UK
29th August 2019 - News analysis |
The panel largely responsible for recommending which drugs the UK’s National Health Service (NHS) should provide may discourage use of the CBD-based drug Epidyolex
Drug trial Project Twenty21 aims to recruit 20,000 medical cannabis users
23rd August 2019 - News analysis |
An organisation led by a former UK government advisor is proposing a significant new medical cannabis study, potentially providing treatment to thousands of patients
CBD vaping brought into the questions over US lung disease outbreak
23rd August 2019 - News analysis |
CBD is being brought reluctantly into the recent growing concern surrounding an unexplained lung condition affecting more than 120 people across the US
